NCT01776541 Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults Status COMPLETED Phase PHASE2
NCT01766921 Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects Status COMPLETED Phase PHASE2
NCT01742221 Safety and Tolerability of HemaMax™ (rHuIL-12) as Radiation Countermeasure Status COMPLETED Phase PHASE1
NCT01596725 A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2 Status COMPLETED Phase PHASE1
NCT01596322 International HIV Antiretroviral Adherence, Resistance and Survival Status COMPLETED Phase N/A
NCT01594320 A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1 Status COMPLETED Phase PHASE1
NCT01579617 e-SiHLE: An Internet Pregnancy Prevention for Older Teenage Girls Status COMPLETED Phase NA
NCT01561768 A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults Status COMPLETED Phase PHASE2
NCT01514929 A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01491607 Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults Status COMPLETED Phase PHASE3
NCT01462136 PK Study of ACHN-490 Injection in Renally Impaired Subjects Status COMPLETED Phase PHASE1
NCT01297543 Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT01265745 Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects Status COMPLETED Phase PHASE1
NCT01263691 Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults Status COMPLETED Phase PHASE1